摘要
目的通过分析近3年上海市样本医院麻醉药使用情况,了解上海市麻醉药发展现状及趋势,为临床合理用药提供参考。方法通过中国医药工业信息中心医院处方分析系统数据库采集的上海市样本医院2020年至2022年麻醉药临床抽样数据,分析麻醉药近3年来的临床应用情况。结果受国家集采影响,部分非管制麻醉药价格下调,麻醉药整体呈下降趋势,门急诊尤为明显,三级医院和二级医院门急诊处方金额复合增长率分别为-11.89%及-26.63%。各级医疗机构均次费用不同程度下降,三级医院和二级医院门急诊均次费用复合增长率分别为-20.57%及-27.16%。吸入麻醉药的可控性和精准性增加,使用方便,临床应用不断拓宽,成长性良好。近年来获批药物增加,国产1类新药的问世,以及产品更新迭代使麻醉药的临床选择性增大。临床仍以单独用药居多,处方张数占比80.65%。结论上海市样本医院麻醉药管控措施积极、有效,但仍需积极探索多药联用方案。
Objective By analyzing the utilization of anesthesia drugs in sample hospitals in Shanghai in recent three years,the development status and trend of anesthesia drugs was understood,so as to provide reference for clinical rational drug use.Methods The clinical sampling data of anesthesia drugs in sample hospitals in Shanghai from 2020 to 2022 were collected from the Hospital Prescription Analysis System database of China National Pharmaceutical Industry Information Center to analyze the clinical application of anesthesia drugs in the recent three years.Results Under the influence of centralized drug quantity purchase policy,the price of some non-controlled anesthetics decreased,and the overall anesthesia drugs showed a downward trend,especially in outpatient and emergency departments.The compound growth rate of outpatient and emergency prescriptions in tertiary hospitals and secondary hospitals was -11.89% and -26.63%,respectively.The average cost of medical institutions at all levels decreased to different degrees,and the average compound growth rate of outpatient and emergency costs in tertiary hospitals and secondary hospitals was -20.57% and -27.16%,respectively.Due to the controllability,accuracy and convenience of inhalation anesthetics,the clinical application is expanded and the growth is good.In recent years,the increase of approved drugs and the advent of domestic class I of innovative drugs and product update iteration have increased the clinical selectivity of anesthetics.Clinical use of drugs alone is still the majority and the number of prescriptions accounted for 80.65%.Conclusions The anesthetics control measures of Shanghai sample hospitals are active and effective,but the multi-drug combination scheme still needs to be actively explored.
作者
姚燕
马伟
YAO Yan;MA Wei(China National Pharmaceutical Industry Information Center,Shanghai 200040,China;Department of Anesthesiology,the International Peace Maternal and Child Health Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200030,China)
出处
《世界临床药物》
CAS
2023年第12期1345-1350,共6页
World Clinical Drug
关键词
麻醉药
应用分析
处方分析
anesthesia drug
application analysis
prescription analysis